
Prospective Evaluation of Patients with Early-/Intermediate-stage Hepatocellular Carcinoma with Disease Progression Following Arterial Locoregional Therapy: Candidacy for Systemic Treatment or Clinical Trials
Keywords: BCLC; Barcelona Clinic Liver Cancer; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy; NCT; National Clinical Trials; PD; progressive disease; TTP; time to progression; UNOS; United Network fo